Cargando…
Accelerated Repurposing and Drug Development of Pulmonary Hypertension Therapies for COVID-19 Treatment Using an AI-Integrated Biosimulation Platform
The COVID-19 pandemic has reached over 100 million worldwide. Due to the multi-targeted nature of the virus, it is clear that drugs providing anti-COVID-19 effects need to be developed at an accelerated rate, and a combinatorial approach may stand to be more successful than a single drug therapy. Am...
Autores principales: | Chakravarty, Kaushik, Antontsev, Victor G., Khotimchenko, Maksim, Gupta, Nilesh, Jagarapu, Aditya, Bundey, Yogesh, Hou, Hypatia, Maharao, Neha, Varshney, Jyotika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037385/ https://www.ncbi.nlm.nih.gov/pubmed/33805419 http://dx.doi.org/10.3390/molecules26071912 |
Ejemplares similares
-
A hybrid modeling approach for assessing mechanistic models of small molecule partitioning in vivo using a machine learning-integrated modeling platform
por: Antontsev, Victor, et al.
Publicado: (2021) -
Molecular Simulation and Statistical Learning Methods toward Predicting Drug–Polymer Amorphous Solid Dispersion Miscibility, Stability, and Formulation Design
por: Walden, Daniel M., et al.
Publicado: (2021) -
In Silico Simulation of the Systemic Drug Exposure Following the Topical Application of Opioid Analgesics in Patients with Cutaneous Lesions
por: Khotimchenko, Maksim, et al.
Publicado: (2021) -
Scalable in silico Simulation of Transdermal Drug Permeability: Application of BIOiSIM Platform
por: Maharao, Neha, et al.
Publicado: (2020) -
Integrating AI/ML Models for Patient Stratification Leveraging Omics Dataset and Clinical Biomarkers from COVID-19 Patients: A Promising Approach to Personalized Medicine
por: Bello, Babatunde, et al.
Publicado: (2023)